Real-World Supported Unprotected Left Main Percutaneous Coronary Intervention with the Impella® Device

December 21, 2017

“This is an area of intense interest to myself and my team at the Detroit Medical Center. Our experience in left main coronary intervention and circulatory support is extensive.”

Dr. Ted Schreiber of the Detroit Medical Center Heart Hospital discusses his clinical publication, Real-World Supported Unprotected Left Main Percutaneous Coronary Intervention with Impella Device, published in Catheterization and Cardiovascular Interventions.

Dr. Schreiber reviews the analysis and puts the data into the context of clinical practice. In this analysis, investigators evaluated 127 consecutive patients with ULM who received Impella device support during ULM PCI. This single center retrospective evaluation of the cVAD Registry further supports the feasibility, safety, and hemodynamic usefulness of Impella devices for providing acceptable in-hospital and 30-day MACCE rates among critically ill patients undergoing unprotected left main intervention.

Related Content:

Subscribe, Tweet this or join the conversation by following us on Twitter: @ProtectedPCI

IMP-200-17

To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/

Subscribe to the Digital Community

Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.

Subscribe to the Digital Community

Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.